Key result
Predischarge natriuretic peptide targets in acute decompensated heart failure may unnecessarily prolong hospital stay.
Why the study?
The association between achieving predischarge natriuretic peptide thresholds and reduced heart failure mortality and readmissions requires cautious evaluation.
Answers are grounded in this paper and cite their sources.
Avoid predischarge natriuretic peptide thresholds for discharge decisions in acute decompensated heart failure; leaves open effects on hard outcomes.
Letters20 June 2017Brain-Type Natriuretic Peptide and Amino-Terminal Pro–Brain-Type Natriuretic Peptide Discharge Thresholds for Acute Decompensated Heart FailureNeil J. Nusbaum, JD, MDNeil J. Nusbaum, JD, MDFrom West Texas VA Health Care System, Big Spring, Texas.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L17-0193 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:McQuade and colleagues (1) suggest that achieving predischarge natriuretic peptide (NP) thresholds is associated with reduced heart failure mortality and readmissions. Although this proposed association has biological plausibility, it should be evaluated with caution. One suspects that clinicians would hesitate to discharge patients who seem clinically unstable even if their NP level had decreased. As a result, patients would tend to remain hospitalized longer if their discharge was contingent on achieving both the clinical appearance of stability and a decreasing NP level rather than solely the former. A longer hospital stay in turn would mean that an ...Reference1. McQuade CN, Mizus M, Wald JW, Goldberg L, Jessup M, Umscheid CA. Brain-type natriuretic peptide and amino-terminal pro–brain-type natriuretic peptide discharge thresholds for acute decompensated heart failure: a systematic review. Ann Intern Med. 2017;166:180-90. [PMID: 27894126]. doi:10.7326/M16-1468 LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From West Texas VA Health Care System, Big Spring, Texas.Disclaimer: The views expressed here are those of the author and are not necessarily those of the Department of Veterans Affairs.Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L17-0193. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoBrain-Type Natriuretic Peptide and Amino-Terminal Pro–Brain-Type Natriuretic Peptide Discharge Thresholds for Acute Decompensated Heart Failure Casey N. McQuade , Marisa Mizus , Joyce W. Wald , Lee Goldberg , Mariell Jessup , and Craig A. Umscheid Brain-Type Natriuretic Peptide and Amino-Terminal Pro–Brain-Type Natriuretic Peptide Discharge Thresholds for Acute Decompensated Heart Failure Casey N. McQuade and Craig A. Umscheid Metrics 20 June 2017Volume 166, Issue 12Page: 915KeywordsConflicts of interestDisclosureHeart failureHospitalizationsLength of stayMortalityNatriuretic peptidesOutpatient clinicsOutpatients ePublished: 20 June 2017 Issue Published: 20 June 2017 Copyright & PermissionsCopyright © 2017 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Neil Jay Nusbaum (2017) conducted a letter in Acute Decompensated Heart Failure. Predischarge natriuretic peptide (NP) thresholds was evaluated on Heart failure mortality and readmissions. Requiring patients with acute decompensated heart failure to achieve predischarge natriuretic peptide thresholds may inadvertently prolong hospital length of stay.
Synapse has enriched 10 related papers. Consider them for comparative context: